Recent advances in engineering prodrug-based nanomedicines for cancer therapy
Open Access
- 8 May 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 5 (11) , 4634-4659
Abstract
This review focuses on updates regarding a broad spectrum of fabrication advances and applications in the field of prodrug-based nanotechnologies in multiple cancer therapeutic strategies in response to the tumor microenvironment.Keywords
Funding Information
- Zhejiang University (519400-11103)
This publication has 163 references indexed in Scilit:
- A Focus on “Bio” in Bio–Nanoscience: The Impact of Biological Factors on Nanomaterial InteractionsAdvanced Healthcare Materials, 2021
- Intracellular Nanoparticle Formation and Hydroxychloroquine Release for Autophagy‐Inhibited Mild‐Temperature Photothermal Therapy for TumorsAdvanced Functional Materials, 2021
- Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade ReactionsAdvanced Healthcare Materials, 2021
- Polypeptides–Drug Conjugates for Anticancer TherapyAdvanced Healthcare Materials, 2021
- Upregulating Aggregation‐Induced‐Emission Nanoparticles with Blood–Tumor‐Barrier Permeability for Precise Photothermal Eradication of Brain Tumors and Induction of Local Immune ResponsesAdvanced Materials, 2021
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast CancersAdvanced Materials, 2019
- Nanoparticle‐Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral ResponsesAdvanced Materials, 2018
- Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor MicroenvironmentAdvanced Materials, 2018
- Rational Design of Cancer Nanomedicine: Nanoproperty Integration and SynchronizationAdvanced Materials, 2017